SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001174947-16-002544
Filing Date
2016-04-28
Accepted
2016-04-28 14:19:40
Documents
3
Period of Report
2016-06-21
Effectiveness Date
2016-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A c437962_def14a.htm DEF 14A 385993
2 GRAPHIC card1.jpg GRAPHIC 88998
3 GRAPHIC card2.jpg GRAPHIC 99685
  Complete submission text file 0001174947-16-002544.txt   647103
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37568 | Film No.: 161599096
SIC: 2834 Pharmaceutical Preparations